Delivery Order SPE2DR25D2206-SPE2DR26F9DH7
Award Date 11/26/25
Potential Completion Date 12/18/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,816.90 to supply CABENUVA ER 600 MG-900 MG Suspension 6ML, a long-acting injectable antiretroviral medication used for HIV treatment. This firm fixed price, competitively awarded delivery order is scheduled for completion by July 14, 2025, and is being performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract is part of the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $40,224.30 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $8,184.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 9, 2026, with completion targeted for February 2, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting...
- The Defense Logistics Agency awarded a $38,169.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), with an ultimate completion date of May 15, 2025. This non-set-aside competitive award represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $22,901.40 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6ML) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,633.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 ml units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable HIV treatment medication, reflecting the company's role in...
- The Defense Logistics Agency awarded a delivery order valued at $4,092.11 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6ML) on January 21, 2026, with completion targeted for February 11, 2026. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,169 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on August 22, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, representing the company's...
- The Defense Logistics Agency awarded a $7,633.80 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with a firm fixed price structure and an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $18,617.58 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the Defense...